A Novel Acyl-CoA: Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor, GSK2973980A, Inhibits Postprandial Triglycerides and Reduces Body Weight in a Rodent Diet-induced Obesity Model
Journal Title: Journal of Pharmaceutical Research International - Year 2017, Vol 18, Issue 6
Abstract
Background and Aim: Acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) is a key enzyme catalyzing the final step of triglyceride (TG) synthesis and is implicated in fat absorption and disposition. However, development of several DGAT1 inhibitors has been hampered due to unacceptable gastrointestinal (GI) tolerability observed in clinical trials. Our aim is to develop a novel, potent and selective DGAT1 inhibitor that reduces plasma TG levels and body weight with acceptable GI tolerability in a rodent model of obesity. Study Design: In vitro enzyme and cellular assays as well as in vivo experimental studies in mice and rat examining the effect of drugs on triglycerides, fecal fat, body weight and food intake. Place and Duration of Study: Virtual proof of concept, GSK USA & Cellzome, GSK Germany and Collaborative research, GVK, India between 2011-2017. Methodology: A radiometric assay of TG formation evaluated DGAT activity and a thermal shift assay determined target specificity. Fasted mice received an oral corn oil bolus to model hypertriglyceridemia. Intralipid administration in fasted rats was used to evaluate triglyceride clearance. Mice were fed a high fat diet to induce obesity. Results: Herein, we describe GSK2973980A as a novel, potent and selective DGAT1 inhibitor that reduced plasma TG levels in postprandial lipid excursion and impaired clearance studies in rodents and reduced body weight and food intake in obese mice. Interestingly, robust plasma TG reduction was accompanied by varying degrees of fecal lipid excretion. Alternate dosing via the subcutaneous route maintained a significant effect on plasma TG reduction with no altered fecal lipid excretion, suggesting GI tolerability may be modulated by limiting local GI exposure of DGAT1 inhibitors. Conclusion: Our data suggest that the impaired TG clearance model in the rat can be used to identify DGAT1 inhibitors with potentially better GI tolerability.
Authors and Affiliations
Sanjay Kumar, Vijaya G. Tirunagaru, Jennifer Ariazi, Amit Awasthi, Venkatesh Babu Jayaraman, Premkumar Arumugam, Mahesh Yanamandra, Sayan Mitra, Sudhir Tiwari, Raghuram S. Tangirala, Thilo Werner, Douglas Thomson, Giovanna Bergamini, Mui Cheung
Keywords
Related Articles
- EP ID EP313127
- DOI 10.9734/JPRI/2017/36835
- Views 83
- Downloads 0
In vitro Antioxidant, Antihyperglycaemic and Antihyperlipidaemic Activities of Ethanol Extract of Lawsonia inermis Leaves
Aim: This present study investigated the free radical scavenging activities, antihperglycaemic and antihyperlipidaemic activities of ethanol extract of Lawsonia inermis leaves. Study Design: Twenty male rats were randoml...
Pharmacists Perception of Physicians and Patients Responses towards Suggested Drug Alternative
Objective: This study aims to analyze the perceived responses from physicians and patients towards an alternative drug suggested by pharmacist in a physician prescription and to observe the reasons for rejection from phy...
Review of Traditionally Used Medicinal Plants by the Kipsigis Community in Kenya
Background: Every community in Kenya have their own ways of providing good health care services for its members. Such services are geared towards providing therapeutic and medical related services for the upkeep of good...
Gender Variation Studies in Dermatoglyphic Patterns (Level 2 Details) of the Ikwerre Ethnic Group in Rivers State, Nigeria
Background to the Study: Dermatoglyphics have had several definitions but each boils down to a simple sentence ‘act, process or science of studying ridge patterns on the skin of the palm, fingers, foot and toes of primat...
Antiplasmodial Activity of the Root Extracts of Cochlospermum tinctorium in Mice Experimentally Infected with Clinical Isolates of Plasmodium berghei berghei (NK 65)
Aims: To determine in vivo the antiplasmodial activity of two chromatographic fractions obtained from Cochlospermum tinctorium A. Rich root bark extract against Plasmodium berghei berghei in mice. Methodology: Two chroma...